Apollo Medical Holdings, Inc. Peer Comparison
Metric | Value | Ranking | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $1.8 Billion | 11/14 | UHS $11.8B |
EHC $9.9B |
ENSG $7.2B |
OPCH $5.4B |
ACHC $3.8B |
SGRY $3.3B |
AMED $3.0B |
LFST $3.0B |
SEM $2.4B |
ADUS $2.1B |
AMEH $1.8B |
PNTG $890.7M |
HCSG $784.9M |
INNV $457.1M |
Gross Margin | 21% | 8/14 | PNTG 100% |
ACHC 96% |
AMED 77% |
UHS 72% |
EHC 46% |
ADUS 33% |
SGRY 23% |
AMEH 21% |
OPCH 20% |
INNV 17% |
HCSG 15% |
ENSG 15% |
SEM 11% |
LFST -48% |
Profit Margin | 6% | 7/14 | EHC 9% |
ACHC 8% |
UHS 7% |
AMED 7% |
ADUS 7% |
ENSG 7% |
AMEH 6% |
OPCH 4% |
HCSG 3% |
SEM 3% |
PNTG 3% |
INNV -2% |
LFST -2% |
SGRY -4% |
EBITDA margin | 12% | 6/14 | LFST 177% |
SEM 88% |
ACHC 20% |
EHC 19% |
UHS 13% |
AMEH 12% |
ENSG 11% |
ADUS 10% |
OPCH 8% |
HCSG 5% |
AMED 4% |
PNTG 3% |
INNV 1% |
SGRY -5% |
Quarterly Revenue | $348.2 Million | 10/14 | UHS $4.0B |
SEM $1.8B |
EHC $1.4B |
OPCH $1.3B |
ENSG $1.1B |
ACHC $815.6M |
SGRY $770.4M |
AMED $587.7M |
HCSG $428.1M |
AMEH $348.2M |
LFST $312.7M |
ADUS $289.8M |
INNV $205.1M |
PNTG $180.7M |
Quarterly Earnings | $22.1 Million | 8/14 | UHS $258.7M |
EHC $120.9M |
ENSG $78.4M |
ACHC $68.1M |
SEM $55.6M |
OPCH $53.9M |
AMED $41.5M |
AMEH $22.1M |
ADUS $20.2M |
HCSG $14.0M |
PNTG $6.2M |
INNV -$4.9M |
LFST -$6.0M |
SGRY -$31.7M |
Quarterly Free Cash Flow | $11.3 Million | 10/14 | SEM $289.0M |
OPCH $150.7M |
AMED $104.2M |
ENSG $89.0M |
UHS $81.9M |
ADUS $46.6M |
SGRY $45.0M |
PNTG $18.2M |
LFST $17.7M |
AMEH $11.3M |
HCSG $2.9M |
INNV -$9.7M |
ACHC -$27.1M |
EHC -$0 |
Trailing 4 Quarters Revenue | $1.3 Billion | 10/14 | UHS $15.4B |
SEM $7.0B |
EHC $5.4B |
OPCH $4.8B |
ENSG $4.1B |
ACHC $3.1B |
SGRY $3.0B |
AMED $2.3B |
HCSG $1.7B |
AMEH $1.3B |
LFST $1.2B |
ADUS $1.1B |
INNV $786.5M |
PNTG $652.3M |
Trailing 4 Quarters Earnings | $50.3 Million | 9/14 | UHS $4.0B |
SEM $1.8B |
EHC $1.4B |
OPCH $1.3B |
ENSG $1.1B |
ACHC $815.6M |
SGRY $770.4M |
AMED $587.7M |
HCSG $428.1M |
AMEH $348.2M |
LFST $312.7M |
ADUS $289.8M |
INNV $205.1M |
PNTG $180.7M |
Quarterly Earnings Growth | -15% | 13/14 | HCSG 355% |
ACHC 131% |
LFST 90% |
AMED 60% |
UHS 55% |
INNV 52% |
PNTG 42% |
EHC 38% |
ADUS 31% |
ENSG 23% |
SEM 15% |
OPCH -4% |
AMEH -15% |
SGRY -188% |
Annual Earnings Growth | -16% | 12/14 | ACHC 34630% |
AMED 159% |
HCSG 147% |
PNTG 66% |
INNV 64% |
LFST 52% |
UHS 51% |
EHC 33% |
ADUS 23% |
SEM -3% |
ENSG -6% |
AMEH -16% |
OPCH -48% |
SGRY -101% |
Quarterly Revenue Growth | 10% | 9/14 | PNTG 29% |
LFST 19% |
OPCH 17% |
ENSG 15% |
SGRY 14% |
EHC 13% |
INNV 12% |
UHS 11% |
AMEH 10% |
ACHC 9% |
ADUS 7% |
SEM 6% |
AMED 6% |
HCSG 4% |
Annual Revenue Growth | 18% | 2/14 | PNTG 21% |
AMEH 18% |
LFST 16% |
SGRY 12% |
OPCH 11% |
EHC 10% |
ENSG 10% |
INNV 10% |
UHS 9% |
ADUS 8% |
ACHC 6% |
AMED 5% |
SEM 4% |
HCSG 2% |
Cash On Hand | $103.2 Million | 8/14 | ENSG $532.1M |
OPCH $483.0M |
AMED $245.5M |
ADUS $222.9M |
SGRY $221.8M |
SEM $191.5M |
UHS $106.1M |
AMEH $103.2M |
LFST $102.6M |
EHC $85.4M |
ACHC $82.1M |
HCSG $53.2M |
INNV $39.0M |
PNTG $4.5M |
Short Term Debt | $3.2 Million | 14/14 | SEM $292.6M |
EHC $164.9M |
UHS $111.2M |
SGRY $97.3M |
ACHC $71.7M |
AMED $63.9M |
LFST $49.0M |
HCSG $25.0M |
INNV $23.1M |
PNTG $19.1M |
ADUS $11.2M |
OPCH $6.5M |
ENSG $4.1M |
AMEH $3.2M |
Long Term Debt | $0 | 14/14 | UHS $5.0B |
SEM $4.3B |
SGRY $3.4B |
ACHC $1.8B |
OPCH $1.1B |
LFST $437.7M |
AMED $404.6M |
PNTG $357.8M |
EHC $189.7M |
ENSG $142.6M |
INNV $96.5M |
ADUS $38.6M |
HCSG $9.0M |
AMEH $0 |
PE | 36.37 | 2/14 | PNTG 42.11 |
AMEH 36.37 |
ENSG 30.20 |
ADUS 28.13 |
OPCH 25.96 |
AMED 23.80 |
EHC 21.67 |
HCSG 15.65 |
ACHC 13.66 |
UHS 11.52 |
SEM 8.65 |
SGRY -1.00 |
INNV -1.00 |
LFST -1.00 |
PS | 1.38 | 5/14 | LFST 2.49 |
EHC 1.84 |
ADUS 1.83 |
ENSG 1.78 |
AMEH 1.38 |
PNTG 1.37 |
AMED 1.31 |
ACHC 1.23 |
OPCH 1.14 |
SGRY 1.10 |
UHS 0.77 |
INNV 0.58 |
HCSG 0.46 |
SEM 0.34 |
PB | 2.17 | 7/14 | PNTG 4.76 |
ENSG 4.14 |
OPCH 3.80 |
EHC 3.47 |
AMED 2.53 |
ADUS 2.19 |
AMEH 2.17 |
LFST 2.09 |
UHS 1.77 |
SGRY 1.73 |
HCSG 1.61 |
INNV 1.57 |
ACHC 1.22 |
SEM 1.03 |
PC | 17.73 | 6/14 | PNTG 199.52 |
EHC 115.65 |
UHS 111.46 |
ACHC 46.68 |
LFST 29.31 |
AMEH 17.73 |
SGRY 14.76 |
HCSG 14.75 |
ENSG 13.62 |
AMED 12.37 |
SEM 12.33 |
INNV 11.72 |
OPCH 11.22 |
ADUS 9.30 |
Liabilities to Equity | 0.00 | 14/14 | SEM 2.98 |
SGRY 2.97 |
PNTG 2.71 |
ENSG 1.65 |
OPCH 1.40 |
EHC 1.32 |
UHS 1.15 |
INNV 0.91 |
ACHC 0.90 |
AMED 0.82 |
HCSG 0.65 |
LFST 0.47 |
ADUS 0.22 |
AMEH 0.00 |
ROA | 0.06 | 3/14 | UHS 7% | EHC 7% | AMEH 6% | HCSG 6% | AMED 6% | ADUS 6% | OPCH 6% | ACHC 5% | ENSG 5% | SEM 3% | PNTG 3% | SGRY 0% | INNV -3% | LFST -5% |
ROE | -1.00 | 14/14 | EHC 16% |
UHS 15% |
OPCH 15% |
SEM 14% |
ENSG 14% |
PNTG 12% |
AMED 11% |
HCSG 10% |
ACHC 9% |
ADUS 8% |
SGRY 0% |
INNV -6% |
LFST -7% |
AMEH -100% |
Current Ratio | 30.71 | 1/14 | AMEH 30.71 |
ADUS 5.62 |
LFST 3.14 |
HCSG 2.54 |
AMED 2.28 |
INNV 2.23 |
ACHC 2.15 |
UHS 1.87 |
EHC 1.77 |
OPCH 1.71 |
ENSG 1.61 |
PNTG 1.41 |
SEM 1.40 |
SGRY 1.34 |
Quick Ratio | 3.65 | 1/14 | PNTG 42.11 |
AMEH 36.37 |
ENSG 30.20 |
ADUS 28.13 |
OPCH 25.96 |
AMED 23.80 |
EHC 21.67 |
HCSG 15.65 |
ACHC 13.66 |
UHS 11.52 |
SEM 8.65 |
SGRY -1.00 |
INNV -1.00 |
LFST -1.00 |
Long Term Debt to Equity | -1.00 | 14/14 | SEM} 2.23 |
PNTG} 2.11 |
SGRY} 1.78 |
OPCH} 0.77 |
UHS} 0.75 |
ACHC} 0.60 |
INNV} 0.37 |
AMED} 0.35 |
LFST} 0.30 |
ENSG} 0.08 |
EHC} 0.07 |
ADUS} 0.04 |
HCSG} 0.02 |
AMEH} -1.00 |
Debt to Equity | -1.00 | 14/14 | SEM 2.38 |
PNTG 2.23 |
SGRY 1.83 |
OPCH 0.78 |
UHS 0.76 |
ACHC 0.62 |
INNV 0.42 |
AMED 0.41 |
LFST 0.34 |
EHC 0.13 |
ENSG 0.08 |
HCSG 0.07 |
ADUS 0.05 |
AMEH -1.00 |
Burn Rate | -4.86 | 9/14 | ACHC 3.74 |
LFST 2.87 |
INNV 2.68 |
SGRY 1.16 |
SEM 1.02 |
PNTG 0.35 |
EHC -1.18 |
UHS -3.41 |
AMEH -4.86 |
HCSG -7.17 |
ENSG -7.42 |
ADUS -14.08 |
AMED -26.41 |
OPCH -60.20 |
Cash to Cap | 0.06 | 9/14 | ADUS 0.11 |
OPCH 0.09 |
INNV 0.09 |
SEM 0.08 |
AMED 0.08 |
HCSG 0.07 |
SGRY 0.07 |
ENSG 0.07 |
AMEH 0.06 |
LFST 0.03 |
ACHC 0.02 |
UHS 0.01 |
EHC 0.01 |
PNTG 0.01 |
CCR | 0.51 | 8/14 | SEM 5.20 |
PNTG 2.93 |
OPCH 2.80 |
AMED 2.51 |
ADUS 2.31 |
INNV 1.97 |
ENSG 1.14 |
AMEH 0.51 |
UHS 0.32 |
HCSG 0.21 |
ACHC -0.40 |
SGRY -1.42 |
LFST -2.97 |
EHC |
EV to EBITDA | 39.93 | 7/14 | INNV} 392.03 |
PNTG} 205.05 |
AMED} 125.37 |
ADUS} 66.62 |
OPCH} 59.83 |
ENSG} 56.16 |
AMEH} 39.93 |
EHC} 37.65 |
HCSG} 33.91 |
ACHC} 33.88 |
UHS} 31.83 |
LFST} 6.12 |
SEM} 4.34 |
SGRY} -181.37 |
EV to Revenue | 1.31 | 9/14 | LFST 2.81 |
SGRY 2.19 |
PNTG 1.94 |
EHC 1.89 |
ACHC 1.80 |
ENSG 1.68 |
ADUS 1.67 |
AMED 1.40 |
AMEH 1.31 |
OPCH 1.27 |
UHS 1.09 |
SEM 0.97 |
INNV 0.67 |
HCSG 0.45 |